Quest Diagnostics Inc
DGX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|sZ | LOCK|VY&v | LOCK|KDxjj? |
Quest Diagnostics Earnings: M&A in 2024 Sets Stage for Strong 2025
Quest Diagnostics wrapped up 2024 with fourth-quarter results that featured both revenue and earnings growth of 15% year over year, reflecting the impact of key acquisitions made in 2024, including the addition of LifeLabs in Canada.
